Funding Opportunities

Recently announced Requests for Proposals (RFPs), Requests for Applications (RFAs), and other funding opportunities of possible interest to AAA members are listed below by date of posting and remain on the list through the closing date. To search this page for a particular topic, press Ctrl-F, then enter the keyword for which you are searching.

Posted June 22, 2009

Posted June 9, 2009

Posted May 12, 2009

Recovery Act Grand Opportunities GO Grant Submission Deadline Moved to May 29, 2009

Draft Stem Cell Funding Guidelines Issued by NIH for Public Comment
NIH is requesting public comment on draft guidelines entitled "National Institutes of Health Guidelines for Human Stem Cell Research."

Renal Function and Chronic Kidney Disease in Aging (R01)
NIA and NIDDK invite applications that propose basic, clinical, and translational research on chronic kidney disease (CKD) and its consequences in aging and in older persons. Applications should focus on the 1) biology and pathophysiology of CKD in animal models; 2) etiology and pathophysiology of CKD in the elderly; 3) epidemiology and risk factors for the development of CKD with advancing age; and/or 4) diagnosis, medical management and clinical outcomes of CKD in this population.

Renal Function and Chronic Kidney Disease in Aging (R21)
Related to R01 above.

In Vivo Cellular and Molecular Imaging Centers (ICMICs) (P50)
NCI invites new or renewal (competing) applications for P50 Research Center Grants to support interdisciplinary scientific teams conducting cutting-edge cancer molecular imaging research. Letters of intent due September 28, 2009, 2010, 2011; applications dues October 28, 2009, 2010, 2011.

NIH Small Research Grant Program (Parent R03)
The National Institutes of Health (NIH) Investigator-Initiated Small Grant (R03) funding opportunity supports small research projects that can be carried out in a short period of time with limited resources, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

NIH Exploratory/Developmental Research Grant Program (Parent R21)
To encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

Posted April 6, 2009

Guidelines for NIH Grant Reviewers
The NIH Office of Extramural Research has posted a new Web page with Guidelines for Reviewers, available from the Peer Review Policies & Practices page. These various guidelines, while intended for reviewers, are also informative for applicants.

Recovery Act Notice: NIH ARRA Funding Considerations for Applications with Meritorious Scores that Fall Beyond the Pay-line
In general, existing applications eligible for consideration of 2-year funding under the economic stimulus package are defined as applications submitted for funding with FY 2008 or FY 2009 funds that: (a) received meritorious priority scores from the initial peer review process; (b) received approval from an Advisory Council or Board prior to September 30, 2009; and (c) received priority scores that could not otherwise be paid in FY 2008 or 2009.
This policy includes consideration of applications in response to previously announced funding opportunities (e.g., RFAs, PAs, PARs), including those that will be peer reviewed by mid-summer and scheduled to receive Advisory Council or Board review prior to September 30, 2009.  Individual NIH ICs have more detailed information on their own Web sites regarding specific previously announced funding opportunities being considered for ARRA funding. NIH program directors will contact applicant project directors/principal investigators (PD/PIs) about applications under consideration to discuss potential modifications of the Abstract, Specific Aims, Public Health Relevance, and budget.

ARRA Administrative Supplements and Competitive Revisions: Clarifications on Programmatic Limitations and use of Modular Budgets
In March, 2009, the NIH announced the availability of funds under the American Recovery and Reinvestment Act of 2009 (ARRA) for project expansions via competitive revisions (NOT-OD-09-058) and administrative supplements (NOT-OD-09-056), including administrative supplements providing summer research experiences for students and science educators (NOT-OD-09-060).

This Notice clarifies that requests in response to the Notices cited above may be made in excess of programmatic cost limitations or ceilings associated with a program or activity code (e.g., direct costs stipulated for Small Research Grants [R03], Exploratory/ Developmental Grants [R21]). 
If a project was previously funded under a program or activity code with budget limitations or ceilings, these limitations or ceilings are not applicable to ARRA competitive revision and/or administrative supplement requests. Note: All budget requests must be commensurate with the scope of the programmatic request and will be subject to a cost analysis prior to award.  In addition, budgets submitted in competing revisions will be subject to the peer review.

Concerning modular budgets and competitive revision applications, the modular grant concept applies. 

Recovery Act of 2009: NIH Award Terms and Additional Information for Recipients Receiving Recovery Act Grant Funding
The ARRA requires recipients to separately account for, track, monitor, report on, provide for audit of, and closeout of all grant funding provided under the ARRA. NIH is implementing a number of unique business processes to accommodate the separation of ARRA funding from funding provided under the standard NIH appropriation.

Recovery Act Limited Competition: Supporting New Faculty Recruitment to Enhance Research Resources through Biomedical Research Core Centers Application
Provides funding for U.S academic institutions/organizations to support the hiring of newly-recruited faculty to develop research projects within the context of Biomedical Core Centers – communities of multidisciplinary researchers focusing on areas of biomedical research relevant to NIH, such as centers, departments, programs, and/or trans-departmental collaborations or consortia. Core Center Grants provide funding to hire, provide appropriate start-up packages, and develop pilot research projects for newly independent investigators, with the goal of augmenting and expanding the institution’s community of multidisciplinary researchers focusing on areas of biomedical research relevant to NIH.  
Letters of intent due April 29; applications due May 29.

Posted March 24, 2009

Announcing the FY 2009 NIH Directors Bridge Awards
Updates and expands the NIH Director’s Bridge Award (NDBA) initiated in FY 2007. The NDBA provides continued but limited bridge funding for meritorious investigators who just miss the funding cutoff and have minimal support from other sources. The continued funding will permit the PI additional time to strengthen a resubmission application. An NDBA recipient will receive an R56 award for a single year.

Posted March 10, 2009

NIH Challenge Grants in Health and Science Research (RC1)
Based on funding from the American Recovery and Reinvestment Act of 2009, NIH has designated at least $200 million in FYs 2009 & 2010 for a new initiative called the NIH Challenge Grants in Health and Science Research, to fund 200 or more grants, contingent upon the submission of a sufficient number of scientifically meritorious applications. This program will support research on Challenge Topics that address specific scientific and health research challenges in biomedical and behavioral research that will benefit from significant two-year jumpstart funds. The research in these areas should have a high impact in biomedical or behavioral science and/or public health. Opening date is March 27; applications are due by April 27.


Career Enhancement Award for Stem Cell Research (K18)
To encourage investigators to obtain the training and career development they need to appropriately use stem cells in their research. Human embryonic stem cells (hESC) have only recently become available, and most investigators are not prepared to handle, maintain, or properly study hESCs. Likewise, the potential of human adult or cord blood, and even animal, stem cells for understanding, treating, and curing human disease is great. Opening Date: May 12; standard application deadlines.

Posted February 23, 2009

NHLBI Career Transition Award (K22)
To provide highly qualified postdoctoral fellows an opportunity to receive mentored research experience in the NHLBI Division of Intramural Research and then to provide them with bridge funding to facilitate the transition of their research programs as new investigators at extramural institutions. Standard application dates.

Posted January 27, 2009

Mechanism of Alcohol-Induced Organ Damage (R01)
NIAAA seeks applications to study molecular and cellular mechanisms of alcohol-induced organ damage. NIAAA is especially interested in integrative research that elucidates complex mechanisms of injury either common or unique to each organ system, as well as the study of alcohol’s effect on stem cell, embryonic development, and regeneration. Letters of intent due March 2; applications due April 2.

Enhancing Developmental Biology Research at Undergraduate Institutions Academic Research Enhancement Award (R15)
NICHD encourages grant applications to strengthen the developmental biology research environment at educational institutions that provide baccalaureate or advanced degrees, but that have not been major recipients of NIH support. Also to foster the development of novel or underutilized experimental model systems, and to motivate students through exposure and participation in research projects designed to study fundamental processes underlying normal development. Letters of intent due April 13, 2009, 2010, 2011; applications due May 13, 2009, 2010, 2011.

Established Investigator Award in Cancer Prevention & Control (K05)
The NCI Established Investigator Award provides qualified cancer prevention, control, behavioral, and/or population scientists with protected time to devote to research and to mentoring new investigators. Standard application dates.

The NCI Transition Career Development Award (K22)
Continuation of an NCI program to facilitate the transition of investigators, primarily those with clinical doctoral degrees as well as those with doctoral degrees working in the areas of cancer prevention, control, behavioral, or population science research, from the mentored stage of career development in academic cancer research to the independent stage. Standard application dates.

Posted January 12, 2009

Optimization of Small Molecule Probes for the Nervous System (R21)
NIAAA & NIDA seek to facilitate the discovery of new small molecule probes for investigating biological function in the nervous system by providing funding for advanced medicinal chemistry and the biological testing of compounds. Letters of intent due Feb. 3; applications due March 3.

Career Development Award to Promote Diversity in Neuroscience Research (K01)
To provide support and “protected time” (three, four, or five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Multiple submission dates.

The Effects of Alcohol on Glial Cells (R01)
NIAAA seeks applications to study the effects of alcohol on glial cells, glial gene expression, neuroimmune and proinflammatory signaling, glial survival and the consequences of these effects on glial-neuronal communication, neuronal gene expression, activity and survival and on behavioral effects of alcohol. Letters of intent due Feb. 23; applications dues March 26.

The Effects of Alcohol on Glial Cells (R21)
See R01 details above.

Partnering Awards to Support Collaborative Research on the Biology of Aging (R01)
NIA seeks applications from research partners in the U.S. and the (U.K.) to support collaborative research projects focused on understanding the biology of aging.  Letters of intent due Feb. 10; applications due March 10.

NIAMS Small Grant Program for New Investigators (R03)
Small grants to stimulate and facilitate the entry of promising new investigators into research on arthritis and musculoskeletal and skin diseases and injuries. Provides support for pilot research that is likely to lead to a subsequent individual research project grant (R01). Applications due June 23 & October 23, 2009; June 23 & October 22, 2010; June 23 & October 24, 2011.

Probes for Microimaging The Nervous System (SBIR [R43/R44])
Research and development of probes useful in imaging the structure and function of the brain and other parts of the nervous system, with award duration and amounts greater than those routinely allowed under the SBIR programs. Specifically invites applications that propose research and development of probes that generate signals detectable by one or more imaging modalities. Such probes should indicate the structure or function of molecules or subcellular elements of neurons or other cells of the nervous system. Of special interest are applications that propose research and development of novel probes, although significant enhancements of already existing probes are also invited. Grant applications may propose projects that will result in probes solely intended for use in research or probes that might have clinical utility. Starting dates, opening March 5.

Posted December 3, 2008

Mutant Mouse Regional Resource Centers (U42)
The National Center of Research Resources (NCRR) is soliciting new applications from institutions/organizations to further advance the Mutant Mouse Regional Resource Center (MMRRC) program. The MMRRC goal is to identify, acquire, evaluate, characterize, cryopreserve, and distribute mutant mouse strains to qualified biomedical investigators. A regional network of three repositories operate cooperatively, using a mutually agreed upon, defined set of standard operating procedures to serve the needs of the biomedical research community for transgenic, knockout and other genetically-induced mutant mice. Each center is responsible for importing mice from assigned donating investigators, and establishing banks of cryopreserved sperm, embryos, and related materials for distribution to research investigators. Each center also provides services on a fee-for-service basis which include: cryopreservation of mouse embryos and gametes, rederivation of living mice from cryopreserved embryos and sperm, quality control testing for mouse pathogens, and genotyping services. Applications due March 3, 2009.

Posted October 31, 2008

NIH Supports Research Careers by Repaying Student Loan Debt
NIH is now accepting applications for its extramural Loan Repayment Programs (LRPs), and is letting applicants know through it awareness-raising campaign slogan that "You do the research. NIH will repay your student loans." The LRPs repay up to $35,000 of educational loan debt annually for individuals who commit to conducting at least two years of qualified biomedical or behavioral research at a nonprofit institution of their choice. The annual application cycle started Sept. 1 and will continue until Dec. 1, 2008, for the five extramural LRPs: Clinical Research, Pediatric Research, Health Disparities Research, Contraception and Infertility Research, and Clinical Research for Individuals from Disadvantaged Backgrounds. Visit www.lrp.nih.gov for more details and to apply.

The Mouse Gene Development Initiative (R01)
NIAAA seeks applications that propose to 1) map traits associated with addiction by varying environmental factors at different states of development across inbred strains of mice including using, but not limited to, selective breeding strategies, recombinant inbred mice, the collaborative cross, and haplotype associative mapping with inbred strains; or 2) Identify epigenetic and genetic modifiers that under different environmental and developmental conditions produces different phenotypic outcomes in mice carrying a defined genetic variant, (e.g., knockout, CNVs). Letters of intent due December 29; applications due January 27, 2009.

Posted October 20, 2008

NHLBI Cardiac Development Consortium (U01)
NHLBI and the Canadian Institutes of Health Research (CIHR) invite applications to participate in a new NHLBI Cardiac Development Consortium, a cooperative investigative group that will drive an integrated approach to the investigation of cardiovascular development, leading to a comprehensive understanding of the regulatory networks controlling cardiovascular development.  Letters of intent due January 6, 2009; applications due February 6, 2009.

Characterizing the Blood Stem Cell Niche (R01)
NHLBI seeks applications related to the blood stem cell niche, an area critical to advancing stem cell biology and its applications to cellular therapeutics including hematopoietic stem cell transplantation.   Development of conditional genetic knock-out models to test the role of factors in specific cell lineages and imaging technology to facilitate following stem cell engraftment in the niche in vivo are integral to this initiative. Letters of intent due December 8; applications due January 6, 2009.

Circadian-Coupled Cellular Function in Heart, Lung, and Blood Tissue (R01)
NHLBI seeks applications aimed at Phase I translation (T1) of recent advances in understanding the molecular basis of endogenous, self-sustaining daily cycles (circadian) in cellular function and gene expression to improve our understanding of heart, lung, and blood disease pathogenesis.  Letters of intent due December 8; applications due January 6, 2009.

Web Portal for Nonhuman Primate Research Models (U24)
NCRR seeks applications from institutions/ organizations proposing to develop a comprehensive Web portal presenting extensive information on publicly-funded resources that provide nonhuman primates (NHPs) for research.  Applications due January 5, 2009.

Short Courses on Mathematical, Statistical, and Computational Tools for Studying Biological Systems (R25)
NIGMS, NCCAM, NIA, & NIMH seek applications for Research Education Grants (R25) from institutions and organizations to conduct workshops and short courses to improve integration of mathematical, statistical, and computational approaches into biological and/or behavioral research. Support will be limited to activities that reach a wide audience of researchers.  The program announcement is NOT intended for university course or curriculum development.  Standard application dates.

Posted September 9, 2008

Collaborative Studies on Systems Biology of Complex Phenotypes (R01)
The National Institute of General Medical Sciences (NIGMS) invites applications for collaborative research projects that use systems biology approaches to investigate the mechanisms that underlie genetic determination of complex phenotypes. These projects will combine quantitative modeling approaches and experimental validation of predictive models. It is expected that a team of at least two principal investigators (PIs), one with expertise in systems biology and the other with expertise in the genetics of humans or model organisms, will apply for funding under this FOA. Applications from a single investigator or that propose solely data production and accumulation will be considered non-responsive and will not be reviewed. Applications due November 21, 2008.

Posted August 4, 2008

2009 NSF Graduate Research Fellowship
The National Science Foundation invites appllications for the 2009 Graduate Research Fellowship (NSF-GRFP) competition.  This program offers up to 3 years of graduate school support worth over $120,000 to each awardee - last year 913 awards were granted.  Benefits include a $30,000 annual stipend, a $10,500 annual cost of education allowance, a one time $1,000 travel allowance, and access to TeraGrid supercomputing facilities. U.S. citizens, nationals, and permanent residents at or near the beginning of their graduate study seeking research-based Master’s and/or PhD degrees in NSF-supported science (including social science and psychology) and engineering disciplines are eligible to apply.  The application process is expected to open in August 2008 and close early November 2008.  Interested applicants should strongly consider preparing their applications as early as possible to help increase their chances of winning.

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32)
Supports predoctoral, postdoctoral, and short-term research training programs at domestic institutions of higher education to help ensure that a diverse and highly trained workforce is available to assume leadership roles related to the U.S. biomedical, behavioral and clinical research. Standard application dates. 

Fogarty International Research Collaboration – Basic Biomedical (FIRCA-BB) Research Award (R03)
Facilitates collaborative basic biomedical research between scientists supported by NIH and investigators in low- to middle-income countries. All non-AIDS-related biomedical research topics that are supported by the NIH, including basic, clinical, and applied research that does not involve behavioral or social science topics and techniques, are eligible for inclusion under the FIRCA-BB program. Opening date:  August 29; applications due: September 29, 2008; January 28, 2009; May 28, 2009; September 29,2009; January 28, 2010; May 28, 2010; and September 28, 2010.

Posted July 8, 2008

Harnessing Inflammation for Reconstruction of Oral and Craniofacial Tissues (R01)
NIDCR seeks applications that will elucidate the molecular mechanisms of resolution of acute and chronic inflammation, and will develop novel multidisciplinary approaches for predictable control and patterning of tissue inflammatory microenvironments. Will require interdisciplinary and multidisciplinary research that integrates advances in disciplines such as cell and developmental biology, stem cell biology, and immunology, with advances in chemistry, pharmacology, and bioengineering. Multiple PI application strongly encouraged. Letters of intent due Sept. 30; a pplications due Oct. 31. Runs parallel with Exploratory/Developmental (R21) grant (see below).

Harnessing Inflammation for Reconstruction of Oral and Craniofacial Tissues (R21)
Runs parallel with R01 grant (see above). Letters of intent due Sept. 30; applications due Oct. 31.

Posted June 24, 2008

NIGMS National Centers for Systems Biology (P50)
NIGMS invites applications for National Centers for Systems Biology to promote institutional development of pioneering research, research training, and outreach programs focused on systems-level inquiries of biomedical questions within the NIGMS mission. Letters of intent due Sept. 24; applications due Oct. 24.

Integrative Systems Biology Approaches to Auditory Hair Cell Regeneration (R01)
NIDCD invites grant applications using comprehensive systems biology approaches intended to restore lost auditory hair cells and their sensory function following damage to the inner ear from a variety of factors including disease, aminoglycosides, noise, and aging. Runs parallel with NIH Exploratory/Developmental (R21) grant (see below).

Integrative Systems Biology Approaches to Auditory Hair Cell Regeneration (R21)
Runs parallel with R01 grant (see above).

Posted 05/30/08

Core Centers for Musculoskeletal Biology and Medicine (P30)
NIAMS invites applications for Research Core Centers to provide shared facilities and services to groups of established, currently funded investigators addressing scientific problems in musculoskeletal biology and medicine, in order to improve efficiency, accelerate the pace of research, and ensure greater productivity. Letters of intent due June 30; applications due July 30.

Mechanisms of Alcohol-Induced Tissue Injury (R01)
NIAAA and NHLBI are supporting research investigating the Mechanisms of Alcohol Induced Tissue Injury in diverse groups and across the life span. ). Standard receipt dates.

Stem Cells and Cancer (R21)
NCI and NIA encourages research in all aspects of tumor stem cell biology, including the molecular and biochemical regulation of embryonic and adult stem cell behavior relevant to tumor formation. Standard receipt dates.

Posted 04/29/08

Tumor Stem Cells in Cancer Biology, Prevention, and Therapy (P01)
To stimulate research on tumor stem cell biology, including the identification and characterization of specific genetic and functional signatures (e.g., biomarkers) of tumor stem cells. The overall goal is the translation of basic research findings into clinical practice in the contexts of both hematological and solid tumor malignancies.  Letters of intent due June 10; applications due July 10.

Genetic Screens to Enhance Zebrafish Research (R01)
Investigator-initiated applications to exploit the power of the zebrafish as a vertebrate model for biomedical and behavioral research.  Applications proposing to develop new genetic screens of high priority to the zebrafish community that will advance the detection and characterization of genes, pathways, and phenotypes of interest in development and aging, organ formation, neural processes, behavior, sensory processes, physiological processes, and disease processes are welcome.  Letters of intent due August 25, 2008, 2009, 2010; applications due September 24, 2008, 2009, 2010.

Enhancing Zebrafish Research with Research Tools and Techniques (R01)
Investigator-initiated applications to exploit the power of the zebrafish as a vertebrate model for biomedical and behavioral research. Applications proposing to develop new research tools or techniques that are of high priority to the zebrafish community and that will advance the detection and characterization of genes, pathways, and phenotypes of interest in development and aging, organ formation, neural processes, behavior, sensory processing, physiological processes, and disease processes are welcome. Letters of intent due August 17, 2008, 2009, 2010; applications due September 17, 2008, 2009, 2010.

Posted 03/11/08

HHMI Early Career Scientist Competition
The Howard Hughes Medical Institute (HHMI) has announced a new program aimed at researchers who have run their own labs for two to six years and are now at a critical point in establishing their own vibrant, independent research programs.  Through a national competition that opens on March 10, HHMI plans to select as many as 70 early career scientists from a wide range of scientific disciplines relevant to biological and medical inquiry. These scientists, most of whom will be assistant professors at the time of the award, will receive six-year, non-renewable appointments to HHMI and receive the substantial research support necessary to move their research in creative, new directions. HHMI will invest more than $300 million in this first group of scientists and plans a second competition in 2011.  Applications will be accepted between May 1, 2008, and June 10, 2008, at 2 p.m. ET

Molecular Phenotypes for Lung Diseases (R01)
NHLBI award to stimulate research that will define or subcategorize human lung diseases at a molecular level enabling early diagnosis, prognosis, and personalized treatment of these diseases.  The measurement of whole-genome gene expression at the RNA level will be the primary approach to systematically collect molecular phenotyping data for common and rare lung diseases. Letters of intent due April 5; applications due May 5.

Small Grants for Lung Tissue Research (R03)
To promote tissue-based research on COPD (chronic obstructive pulmonary disease) and interstitial fibrotic lung conditions, including studies to establish proof-of-concept in humans for novel mechanisms of pathogenesis. Research must use lung biospecimens and data collected by the Lung Tissue Research Consortium (LTRC).  Letters of intent due April 8 & Sept. 22; applications due May 9 & Oct. 17.

Functional Links between the Immune System, Brain Function and Behavior (R01)
Multi-Institute support to study neuroimmune molecules and mechanisms involved in regulating normal and pathological functions of the central nervous system (CNS).  Standard receipt dates.

Posted 02/26/08

Posted 02/06/08

NIH Director’s New Innovator Award
To support a small number of new investigators of exceptional creativity who propose bold and highly innovative new research approaches with the potential to produce a major impact on broad, important problems in biomedical and behavioral research. Applications due March 31. 

Shared Instrumentation Grant Program (S10)
To purchase or upgrade commercially available instruments that cost at least $100,000; maximum award is $500,000. Types of instruments supported include confocal and electron microscopes, biomedical imagers, mass spectrometers, DNA sequencers, biosensors, cell sorters, X-ray diffraction systems, and NMR spectrometers among others. Applications due: March 24.  

Notice Regarding Authentication of Cultured Cell Lines
NIH believes tmisidentification of cell cultures is a serious problem.  However, because authentication methods can be quite specific and are continuously evolving, it would be impractical for NIH to require application of particular methods in all grant applications.  The peer review process has been designed to carefully examine the experimental approach and assure that the investigators propose appropriate methods and resources for the described study.  Grant applications that fail to employ such practices would not be considered of the highest quality and such manuscripts would not fare well in the journal review process. 

NIH Reduces Temporary “Error Correction Window” for Electronic Grant Applications from Five Business Days to Two
NIH has reduced the “error correction window” (i.e. , the time allowed after the submission deadline to address NIH system identified errors/warnings) from five (5) business days to two (2) business days for all electronically submitted grant applications with submission deadlines on or after January 8.  

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Predoctoral Training Program in Systems Biology of Developmental Biology & Birth Defects (T32)
Letters of intent due April 25, 2008, 2009 and 2010; applications due May 25, 2008, 2009 and 2010.

Innovative Technologies for Molecular Analysis of Cancer (R21)
Exploratory research projects focused on the inception and early stage development of highly innovative cancer-relevant technologies with emphasis on technically innovative molecular analysis tools with the potential to add a new quality to the investigations of the molecular basis of cancer in vitro, in situ, and/or in vivo.  Letters of intent due: April 29, August 24; application due: May 29, September 24. 

NIH Administrative Revisions for Human Pluripotent Stem Cell (hPSC) Research Using Non-Embryonic Sources
One-year administrative revisions for NIH-funded grantees to encourage research into the derivation and/or characterization of human pluripotent stem cells (hPSCs) from non-embryonic sources.  Applications due April 1.

Thyroid in Aging (R01)
To promote basic, translational, and clinical studies leading to increased understanding of the physiology of the aging thyroid and improved diagnosis and management of thyroid disease in older adults. 

Nanoscience and Nanotechnology in Biology and Medicine (R01)
Nanotechnology and nanoscience have the capacity to drive a new wave of medical innovation through the engineering of bioactive nanoscale structures, processes, and systems based on the advancement of our understanding of biology at the nanoscale. Nanoscience and nanotechnology refer to research and development on the understanding and control of matter at a length scale of approximately 1 - 100 nanometers, where novel properties and functions occur because of the size.  

NCI Transition Career Development Award to Promote Diversity (K22)
Primarily for those with clinical doctoral degrees as well as those with doctoral degrees working in the areas of cancer prevention, control, behavioral, or population science research, from the mentored stage of career development in academic cancer research to the independent stage.

Posted 01/09/08

Short Courses in Integrative and Organ Systems Pharmacology (R25)
Development and delivery of short courses (2-3 weeks intensive training) to introduce students to the knowledge and skills needed for studies of integrative organ system and whole organism biological responses to drugs and other physiological perturbations
Letters of intent due January 26; applications due February 26.

Nanoscience and Nanotechnology in Biology and Medicine (R01)
A major challenge facing medicine is to develop novel and more sophisticated approaches for the diagnosis, treatment and management of an array of diseases and traumatic injuries. Nanotechnology and nanoscience have the capacity to drive a new wave of medical innovation through the engineering of bioactive nanoscale structures, processes, and systems based on the advancement of our understanding of biology at the nanoscale. Nanoscience and nanotechnology refer to research and development on the understanding and control of matter at a length scale of approximately 1 - 100 nanometers, where novel properties and functions occur because of the size.

Nanoscience and Nanotechnology in Biology and Medicine (R21)
See details above.

NCI Transition Career Development Award to Promote Diversity (K22)
To facilitate the transition of investigators from minority groups underrepresented in biomedical research, primarily those with clinical doctoral degrees as well as those with doctoral degrees working in the areas of cancer prevention, control, behavioral, or population science research, from the mentored stage of career development in academic cancer research to the independent stage.

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Predoctoral Training Program in Systems Biology of Developmental Biology & Birth Defects (T32)
National Institute of Child Health and Human Development (NICHD)